Clinical Trial Update: A Safety and Immunogenicity Trial With an Adjuvanted Tuberculosis(TB) Subunit Vaccine [Phase 1]

View source ↗

Summary

Phase 1 safety and immunogenicity data for an adjuvanted tuberculosis subunit vaccine have been reported as completed. The trial was sponsored by Statens Serum …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Snippet

Sponsor: Statens Serum Institut | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED